An elaborate pathway required for Ras-mediated epigenetic silencing

Nature

Volumn 449, Issue 7165, 2007, Pages 1073-1077

  Gazin, Claude ^a   Wajapeyee, Narendra ^a   Gobeil, Stephane ^a   Virbasius, Ching Man ^a   Green, Michael R ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 1;

CANCER; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC ANALYSIS; METHYLATION; PHENOTYPE; TUMOR;

APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL GROWTH; CELL STRAIN 3T3; CELL TRANSFORMATION; CONTROLLED STUDY; EPIGENETICS; GENE REPRESSION; GENE SILENCING; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC SCREENING; KNOCKOUT GENE; METHYLATION; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE K RAS; ONCOGENE RAS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RNA INTERFERENCE;

EID: 35548953686     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature06251     Document Type: Article

References (25)

1. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57-70 (2000).
2. Baylin, S. B. DNA methylation and gene silencing in cancer. Nature Clin. Pract. Oncol. 2 (Suppl. 1), S4-S11 (2005).
3. Esteller, M. Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br. J. Cancer 94, 179-183 (2006).
4. Jones, P. A. DNA methylation errors and cancer. Cancer Res. 56, 2463-2467 (1996).
5. Baylin, S. & Bestor, T. H. Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell 1, 299-305 (2002).
6. Keshet, I. et al. Evidence for an instructive mechanism of de novo methylation in cancer cells. Nature Genet. 38, 149-153 (2006).
7. Giehl, K. Oncogenic Ras in tumour progression and metastasis. Biol. Chem. 386, 193-205 (2005).
8. Ehmann, F. et al. Detection of N-RAS and K-RAS in their active GTP-bound form in acute myeloid leukemia without activating RAS mutations. Leuk. Lymphoma 47, 1387-1391 (2006).
9. Fenton, R. G., Hixon, J. A., Wright, P. W., Brooks, A. D. & Sayers, T. J. Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras. Cancer Res. 58, 3391-3400 (1998).
10. Peli, J. et al. Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas. EMBO J. 18, 1824-1831 (1999).
11. Osaki, M., Oshimura, M. & Ito, H. PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis 9, 667-676 (2004).
12. ras in activation of extracellular signal-regulated kinase 2. Nature 357, 602-604 (1992).
13. Alfonso, P. et al. Proteomic analysis of p38α mitogen-activated protein kinase-regulated changes in membrane fractions of RAS-transformed fibroblasts. Proteomics 6 (Suppl 1), S262-S271 (2006).
14. Ohm, J. E. et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nature Genet. 39, 237-242 (2007).
15. Schlesinger, Y. et al. Polycomb-mediated methylation on Lys27 of histone H3 premarks genes for de novo methylation in cancer. Nature Genet. 39, 232-236 (2007).
16. Widschwendter, M. et al. Epigenetic stem cell signature in cancer. Nature Genet. 39, 157-158 (2007).
17. Zhou, Y., Santoro, R. & Grummt, I. The chromatin remodeling complex NoRC targets HDAC1 to the ribosomal gene promoter and represses RNA polymerase I transcription. EMBO J. 21, 4632-4640 (2002).
18. Weber, M. et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nature Genet. 37, 853-862 (2005).
19. Rubin, J. S., Barshishat-Kupper, M., Feroze-Merzoug, F. & Xi, Z. F. Secreted WNT antagonists as tumor suppressors: pro and con. Front. Biosci. 11, 2093-2105 (2006).
20. Ranganathan, P. & Rangnekar, V. M. Regulation of cancer cell survival by Par-4. Ann. NY Acad. Sci. 1059, 76-85 (2005).
21. Abdollahi, A. LOT1 (ZAC1/PLAGL1) and its family members: mechanisms and functions. J. Cell. Physiol. 210, 16-25 (2007).
22. Nie, Y. et al. DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas. Carcinogenesis 22, 1615-1623 (2001).
23. Kenyon, K. et al. Lysyl oxidase and rrg messenger RNA. Science 253, 802 (1991).
24. Frommer, M. et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl Acad. Sci. USA 89, 1827-1831 (1992).
25. Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001).